Read our latest updates
News and press releases
News and press releases
Trustee InnoGenerics is looking for opportunities to maintain essential generic drug production in the Netherlands
Press release Leiden, December 14, 8:30 p.m On December 13th, 2022, the court of The Hague appointed Henri Bentfort van Valkenburg as trustee of the bankrupt drug manufacturer InnoGenerics in Leiden. InnoGenerics operates the last remaining factory in The Netherlands
Curator InnoGenerics zoekt mogelijkheden om essentiële generieke geneesmiddelenproductie in Nederland te behouden
Persbericht Leiden, 14 december 20.30 uur Op 13 december 2022 heeft de rechtbank Den Haag Henri Bentfort van Valkenburg benoemd als curator van de failliete geneesmiddelenproducent InnoGenerics in Leiden. InnoGenerics exploiteert de laatste grote fabriek in Nederland die generieke medicijnen
UN Global Compact
We are proud to be a signatory to the UN Global Compact since this year. We have identified six UN Sustainable Development Goals where our work makes a contribution. Find out more at: https://www.innogenerics.com/about-us/sustainability/
We zijn gestart
We zijn ongelofelijk blij, trots en dankbaar dat een belangrijke generieke geneesmiddelenfabrikant van Nederland dankzij de volhardendheid van al onze partners deze week een nieuwe start mag maken onder de vlag van InnoGenerics.
European Commission approves government loan to support largest Dutch drugs maker
The European Commission (EC) has given the Dutch Government approval to support us! We are grateful and feel doubly supported (!) in our mission to do everything to make patients stronger and better – together with our customers and partners.
Cabinet gives drug factory state aid to prevent dependence on foreign countries
Partly because of experiences in the corona crisis, the cabinet is preventing the large Apotex drug factory from having to close. The company is restarting under new Dutch ownership with a loan from the government. The Netherlands and the EU
Trustee InnoGenerics is looking for opportunities to maintain essential generic drug production in the Netherlands
Press release Leiden, December 14, 8:30 p.m On December 13th, 2022, the court of The Hague appointed Henri Bentfort van Valkenburg as trustee of the bankrupt drug manufacturer InnoGenerics in Leiden. InnoGenerics operates the last remaining factory in The Netherlands
Curator InnoGenerics zoekt mogelijkheden om essentiële generieke geneesmiddelenproductie in Nederland te behouden
Persbericht Leiden, 14 december 20.30 uur Op 13 december 2022 heeft de rechtbank Den Haag Henri Bentfort van Valkenburg benoemd als curator van de failliete geneesmiddelenproducent InnoGenerics in Leiden. InnoGenerics exploiteert de laatste grote fabriek in Nederland die generieke medicijnen
UN Global Compact
We are proud to be a signatory to the UN Global Compact since this year. We have identified six UN Sustainable Development Goals where our work makes a contribution. Find out more at: https://www.innogenerics.com/about-us/sustainability/
We zijn gestart
We zijn ongelofelijk blij, trots en dankbaar dat een belangrijke generieke geneesmiddelenfabrikant van Nederland dankzij de volhardendheid van al onze partners deze week een nieuwe start mag maken onder de vlag van InnoGenerics.
European Commission approves government loan to support largest Dutch drugs maker
The European Commission (EC) has given the Dutch Government approval to support us! We are grateful and feel doubly supported (!) in our mission to do everything to make patients stronger and better – together with our customers and partners.
Cabinet gives drug factory state aid to prevent dependence on foreign countries
Partly because of experiences in the corona crisis, the cabinet is preventing the large Apotex drug factory from having to close. The company is restarting under new Dutch ownership with a loan from the government. The Netherlands and the EU
